Breakthrough Invasive Fungal Infection After Coadministration of Venetoclax and Voriconazole
OPEN FORUM INFECTIOUS DISEASES(2023)
摘要
Venetoclax requires a 75% dose reduction when coadministered with voriconazole. In a 10-year historical cohort of treatment with venetoclax, we did not observe a worse hematologic outcome in patients who received voriconazole prophylaxis versus those who did not. Subtherapeutic voriconazole levels and a triazole exposure history may contribute to breakthrough invasive fungal infection.
更多查看译文
关键词
venetoclax,voriconazole,infection,coadministration
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要